Previous Close | 9.47 |
Open | 9.60 |
Bid | 9.51 x 800 |
Ask | 9.89 x 1100 |
Day's Range | 9.49 - 9.76 |
52 Week Range | 7.52 - 10.95 |
Volume | |
Avg. Volume | 341,585 |
Market Cap | 890.621M |
Beta (5Y Monthly) | 0.92 |
PE Ratio (TTM) | 484.50 |
EPS (TTM) | 0.02 |
Earnings Date | Aug 06, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 9.96 |
STNE vs. ENFN: Which Stock Is the Better Value Option?
NEW YORK & LONDON & HONG KONG, July 16, 2024--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, today announced it will release its second quarter 2024 financial results before the U.S. financial markets open on Tuesday, August 6, 2024. Management will host a conference call and webcast that same morning at 5:30 AM (PT) / 8:30 AM (ET) to discuss the results.
On June 20, 2024, Bronwen Bastone, Chief People Officer of Enfusion Inc (NYSE:ENFN), executed a sale of 28,780 shares of the company, according to the SEC Filing. Following this transaction, the insider now owns 198,913 shares of the company. Enfusion Inc (NYSE:ENFN) specializes in providing cloud-based investment management software and services.